Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Delayed Nasdaq
Other stock markets
 20:45:11 29/04/2024 BST 		5-day change 1st Jan Change
25.57 USD +1.67% Intraday chart for Protagonist Therapeutics, Inc. -3.91% +11.51%
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT
03-26 Protagonist Therapeutics, Inc. Provides Update on Verify Patient Enrollment and Timing of Top-Line Data CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. News Protagonist Therapeutics, Inc.
  5. Official Publications